BioLife Solutions, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US09062W2044
USD
25.83
0.46 (1.81%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Artivion, Inc.
Varex Imaging Corp.
BioLife Solutions, Inc.
Treace Medical Concepts, Inc.
Silk Road Medical, Inc.
Embecta Corp.
OrthoPediatrics Corp.
The Beauty Health Co.
Atrion Corp.
Cytek Biosciences, Inc.
Nevro Corp.
Why is BioLife Solutions, Inc. ?
1
The company has declared Positive results for the last 4 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at USD 15.54 MM
  • ROCE(HY) Highest at -5.98%
  • NET PROFIT(9M) Higher at USD -18.29 MM
2
Risky - Negative Operating Profits
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 0.82%, its profits have risen by 83.7%
3
High Institutional Holdings at 100%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Underperformed the market in the last 1 year
  • The stock has generated a return of 0.82% in the last 1 year, much lower than market (S&P 500) returns of 12.33%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to BioLife Solutions, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is BioLife Solutions, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
BioLife Solutions, Inc.
-3.66%
0.50
50.91%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
22.65%
EBIT Growth (5y)
-259.22%
EBIT to Interest (avg)
-24.47
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.21
Sales to Capital Employed (avg)
0.37
Tax Ratio
1.27%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.20
EV to EBIT
-137.15
EV to EBITDA
-1053.88
EV to Capital Employed
3.78
EV to Sales
9.98
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-2.76%
ROE (Latest)
-2.05%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 15.54 MM

ROCE(HY)

Highest at -5.98%

NET PROFIT(9M)

Higher at USD -18.29 MM

CASH AND EQV(HY)

Highest at USD 170.35 MM

-16What is not working for the Company
NET SALES(9M)

At USD 72.07 MM has Grown at -14.37%

OPERATING PROFIT(Q)

Lowest at USD -15.26 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -60.03 %

PRE-TAX PROFIT(Q)

Lowest at USD -15.71 MM

NET PROFIT(Q)

Lowest at USD -15.84 MM

EPS(Q)

Lowest at USD -0.33

Here's what is working for BioLife Solutions, Inc.
Operating Cash Flow
Highest at USD 15.54 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Cash and Eqv
Highest at USD 170.35 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Here's what is not working for BioLife Solutions, Inc.
Pre-Tax Profit
At USD -15.71 MM has Fallen at -986.4%
over average net sales of the previous four periods of USD -1.45 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -15.84 MM has Fallen at -1,023.06%
over average net sales of the previous four periods of USD -1.41 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Net Sales
At USD 72.07 MM has Grown at -14.37%
Year on Year (YoY)
MOJO Watch
Near term sales trend is negative

Net Sales (USD MM)

Operating Profit
Lowest at USD -15.26 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (USD MM)

Operating Profit Margin
Lowest at -60.03 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
Lowest at USD -15.71 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit
Lowest at USD -15.84 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)

EPS
Lowest at USD -0.33
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (USD)